ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE
批准号:
6101351
负责人:
RAYMOND E MEYN
金额:
$21.04万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-15 至 2000-02-29
中文摘要
本研究项目的目的是了解心绞痛的发病机制。
抗辐射,使肿瘤细胞能够逃脱
细胞死亡称为细胞凋亡。它是以实验为基础的
在最后一次资助期间在调查人员的实验室进行
这一时期表明相对容易治愈的肿瘤
显示出大量的细胞凋亡,而肿瘤相对
耐药细胞无细胞凋亡反应。这些结果是一致的
前提是细胞凋亡可能在肿瘤中发挥重要作用
对辐射的反应。然而,由于许多肿瘤似乎是
对这种细胞死亡模式的抵抗是研究人员关注的
描述了生物化学和分子机制
决定了细胞的凋亡倾向。有两条分子途径是
发现了可能解释辐射抗性的
抑制细胞凋亡,这些都是由bcl2控制的
癌基因和P53抑癌基因。的具体目标
本提案旨在理解
更多细节,探索克服其阻挡能力的策略
细胞凋亡,ANC评估它们在反应中的可能作用
放射治疗患者。具体地说,调查人员建议:(1)
确定bcl2癌基因的生化机制
调节细胞凋亡倾向。(2)评估战略
调控P53功能以促进细胞凋亡
耐药肿瘤。(3)研究细胞凋亡在以下方面的可能作用
患者对放射治疗反应的回顾性分析
前处理活组织标本。耐药细胞的存在
肿瘤可能是决定最终治愈的关键因素
患者接受放射治疗。鉴于许多因素已经被
先前检查以测量和预测肿瘤细胞对
辐射后,细胞凋亡倾向是一个相对较新的终点。
该项目的具体目标旨在解决以下角色
细胞凋亡在放射反应中的作用并可能最终影响患者
通过验证预处理的凋亡指数预测治疗
应采取的应对措施和克服抗药性的策略
抑制细胞凋亡倾向。
英文摘要
The goal of this research project is to understand the mechanisms of
radiation-resistance that allow tumor cells to escape the mode of
cell death known as apoptosis. It is based on experiments
conducted in the investigators' laboratory during the last funding
period that indicated that tumors that are relatively easy to cure
display substantial apoptosis whereas tumors that are relatively
resistant have no apoptotic response. These results are consistent
with the premise that apoptosis may play a significant role in tumor
response to radiation. However, since many tumors appear to be
resistant to this mode of cell death the researchers have focused on
delineating the biochemical and molecular mechanisms which
dictate apoptosis propensity. Two molecular pathways have been
uncovered which may account for radiation-resistance through
inhibition of apoptosis and these are controlled by the bcl-2
oncogene and the p53 tumor suppressor gene. The specific aims of
this proposal are directed to understanding these mechanisms in
more detail, exploring strategies to overcome their ability to block
apoptosis, anc evaluate their possible role in the response of
radiotherapy patients. Specifically the investigators propose to: (1)
Determine the biochemical mechanism by which the bcl-2 oncogene
regulates apoptosis propensity. (2) Evaluate strategies for
modulating p53 function in an effort to enhance apoptosis in
resistant tumors. (3) Examine the possible role of apoptosis in
patient response to radiotherapy by retrospective analysis of
pretreatment biopsy specimens. The presence of resistant cells in
tumors may be a critical factor in determining the ultimate cure of
patients by radiotherapy. Whereas many factors have been
examined previously to measure and predict tumor cell sensitivity to
radiation, the propensity for apoptosis is a relatively new endpoint.
The specific aims of this project are designed to address the role of
apoptosis in radiation response and may ultimately impact patient
treatment by verifying that the pretreatment apoptotic index predicts
response and by developing strategies for overcoming resistance due
to suppressed apoptosis propensity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extension of Radiotherapy Research
-
批准号:8711380
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2011
-
负责人:RAYMOND E MEYN
-
依托单位:
Extension of Radiotherapy Research
-
批准号:8509643
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2011
-
负责人:RAYMOND E MEYN
-
依托单位:
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS
-
批准号:6990156
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2004
-
负责人:RAYMOND E MEYN
-
依托单位:
TUMOR CELL RADIOSENSITIZATION BY ADENOVIRAL-MEDIATED P16
-
批准号:6205352
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2000
-
负责人:RAYMOND E MEYN
-
依托单位:
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE
-
批准号:6299885
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2000
-
负责人:RAYMOND E MEYN
-
依托单位:
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE
-
批准号:6268507
-
项目类别:
-
资助金额:$20.18万
-
财政年份:1998
-
负责人:RAYMOND E MEYN
-
依托单位:
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE
-
批准号:6235903
-
项目类别:
-
资助金额:$19.85万
-
财政年份:1997
-
负责人:RAYMOND E MEYN
-
依托单位:
Anticancer Drug Resistance by Bcl-2 Oncogene Expression
-
批准号:7069989
-
项目类别:
-
资助金额:$26.54万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL-2 ONCOGENE EXPRESSION
-
批准号:2712755
-
项目类别:
-
资助金额:$20.54万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION
-
批准号:6376190
-
项目类别:
-
资助金额:$24.86万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL-2 ONCOGENE EXPRESSION
-
批准号:2429875
-
项目类别:
-
资助金额:$19.75万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
Anticancer Drug Resistance by Bcl-2 Oncogene Expression
-
批准号:7223490
-
项目类别:
-
资助金额:$25.77万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION
-
批准号:2899064
-
项目类别:
-
资助金额:$20.6万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
Anticancer Drug Resistance by Bcl-2 Oncogene Expression
-
批准号:6824592
-
项目类别:
-
资助金额:$29.43万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION
-
批准号:6172808
-
项目类别:
-
资助金额:$24.32万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
Anticancer Drug Resistance by Bcl-2 Oncogene Expression
-
批准号:6914198
-
项目类别:
-
资助金额:$27.18万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL-2 ONCOGENE EXPRESSION
-
批准号:2113069
-
项目类别:
-
资助金额:$18.99万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION
-
批准号:6512788
-
项目类别:
-
资助金额:$25.41万
-
财政年份:1996
-
负责人:RAYMOND E MEYN
-
依托单位:
REPAIR OF RADIATION DAMAGE IN VITRO AND VIVO
-
批准号:3167252
-
项目类别:
-
资助金额:$8.19万
-
财政年份:1979
-
负责人:RAYMOND E MEYN
-
依托单位:
REPAIR OF RADIATION DAMAGE IN VITRO AND VIVO
-
批准号:3167251
-
项目类别:
-
资助金额:$8.16万
-
财政年份:1979
-
负责人:RAYMOND E MEYN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: